Cosmos Health (NASDAQ:COSM) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by 500 percent. This is a 100 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $17.928 million which missed the analyst consensus estimate of $21.893 million by 18.11 percent. This is a 30.74 percent increase over sales of $13.713 million the same period last year.